Among the moves blocked by the U.S. Court of Appeals for the 5th Circuit was the FDA's 2019 approval of a GenBioPro's application to market a generic version of mifepristone. The Supreme Court issued a temporary order last week preserving access to the drug until 11:59 p.m. Wednesday, and the hold wasGenBioPro's lawsuit against the FDA is the latest in a legal barrage involving medication abortion that has thrown the availability of mifepristone into uncertainty.
GenBioPro, the country's only manufacturer of generic mifepristone, is asking the court to block the FDA from depriving it"of its constitutional and statutory rights to market mifepristone without affording GenBioPro due process of law." The agency said it does not comment on possible, pending or ongoing litigation.
That & what about green lighting bad chemicals in our food?! Red40. These chemicals are banned in other countries because of how toxic these chemicals are & yet the people at the FDA here in The United States of America green light these harmful chemicals to be in our food!
This drug is bad for women. Beware
Lol, like the DOJ is the problem here…
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: axios - 🏆 302. / 63 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: MsMagazine - 🏆 378. / 59 Read more »